Supporting Microfluidic Drug Sensitivity Analysis Technology Platform

        Hamamatsu Photon Technology (Langfang) Co., Ltd. collaborates with Hunan University to establish a joint laboratory for molecular diagnosis and molecular imaging. The laboratory has developed a microfluidic drug sensitivity analysis technology platform based on the underlying technological innovation of Hunan University. The platform is fast, accurate, and has broad development and application prospects.

Hamamatsu Photon Technology (Langfang) Co., Ltd. utilizes mature modular technologies in fields such as molecular biology and biosensing to quickly complete the design and development of new products. Hamamatsu Photon Technology (Langfang) Co., Ltd. has the development capability of biochemical luminescence technology platform, nucleic acid amplification technology platform, and immune chromatography technology platform.

Through school enterprise cooperation, Hamamatsu Photon Technology (Langfang) Co., Ltd. adheres to technological development and innovation, develops according to customer needs, and is committed to promoting the application and development of inspection and testing instruments.

News on current events